Author details

Full Name

Hsin-Ta Wu

Affiliation

ORCID

Career Start Year

2006

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37601688	Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling-informed personalized monitoring assay.		2023
36253484	A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes.	Nat Cancer	2022
36232827	Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection.	International Journal of Molecular Sciences	2022
36170624	Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse.	JCO Precision Oncology	2022
36117009	Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer.	Gynecol Oncol	2022
30992300	Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence.	Clin Cancer Res	2019
31070691	Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer.	JAMA Oncology	2019
31059311	Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma.	Journal of Clinical Oncology	2019
29112732	Identifying structural variants using linked-read sequencing data.	Bioinformatics	2018
28241635	Optimization of PAM-4 transmitters based on lumped silicon photonic MZMs for high-speed short-reach optical links.	Optics Express	2017
27505681	Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.	Cancer Cell	2016
27165744	Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.	Cancer Cell	2016
27485716	Erratum to: CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer.	Genome Biol	2016
26813760	Reply: Co-occurrence of MYC amplification and TP53 mutations in human cancer.	Nat Genet	2016
26020500	MAGI: visualization and collaborative annotation of genomic aberrations.	Nat Methods	2015
25501392	Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.	Nat Genet	2015
26253137	CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer.	Genome Biol	2015
24732363	Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease.	PLoS One	2014
24931984	Detecting independent and recurrent copy number aberrations using interval graphs.	Bioinformatics	2014
23554878	Identification of ovarian cancer metastatic miRNAs.	PLoS One	2013
23634996	Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.	N Engl J Med	2013
22452995	An integrative probabilistic model for identification of structural variation in sequencing data.	Genome Biol	2012
16644790	An online literature mining tool for protein phosphorylation.	Bioinformatics	2006